What is the current Price Target for the Mereo BioPharma Group plc Sponsored ADR stock?

The average Mereo BioPharma Group plc Sponsored ADR target price is $7.34. This is 108.45% higher than the current stock price. The highest price target is 184.09%, the lowest is 61.93%. 8 Analysts have issued a price target Mereo BioPharma Group plc Sponsored ADR 2025 .

What's going on with the Mereo BioPharma Group plc Sponsored ADR stock today?

The performance of Mereo BioPharma Group plc Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Mereo BioPharma Group plc Sponsored ADR Forecast, price target & analysts

Q: How high will the Mereo BioPharma Group plc Sponsored ADR stock rise?

No reliable answer can be given as to how high the Mereo BioPharma Group plc Sponsored ADR stock will rise. The performance of stocks, including the Mereo BioPharma Group plc Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

Q: Why did the Mereo BioPharma Group plc Sponsored ADR stock fall?

The decline in Mereo BioPharma Group plc Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

$3.52

5.63% yesterday

Nasdaq, Dec 30, 10:00 pm CET

ISIN

US5894921072

Symbol

MREO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Mereo BioPharma Group plc Sponsored ADR Target price 2024 - Analyst rating & recommendation

Mereo BioPharma Group plc Sponsored ADR Classifications & Recommendation:

Buy

100%

Mereo BioPharma Group plc Sponsored ADR Price Target

Target Price	$7.34
Price	$3.52
Potential	108.45% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Mereo BioPharma Group plc Sponsored ADR 2025 . The average Mereo BioPharma Group plc Sponsored ADR target price is $7.34. This is 108.45% register free of charge higher than the current stock price. The highest price target is $10.00 184.09% register free of charge , the lowest is $5.70 61.93% register free of charge .
	A rating was issued by 8 analysts: 8 Analysts recommend Mereo BioPharma Group plc Sponsored ADR to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Mereo BioPharma Group plc Sponsored ADR stock has an average upside potential 2025 of 108.45% register free of charge . Most analysts recommend the Mereo BioPharma Group plc Sponsored ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-0.20	-0.07
	42.86%	65.00%
P/E		negative
EV/Sales		27.77

Based on analysts' sales estimates for 2024, the Mereo BioPharma Group plc Sponsored ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

Unlock

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	56.42	113.96%
2024	27.77 50.78% Unlock
2025	23.92 13.85% Unlock
2026	12.06 49.60% Unlock
2027	8.28 31.31% Unlock
2028	3.65 55.95% Unlock

Current	65.66	111.04%
2024	31.84 51.50% Unlock
2025	27.43 13.85% Unlock
2026	13.83 49.60% Unlock
2027	9.50 31.31% Unlock
2028	4.18 55.95% Unlock

Mereo BioPharma Group plc Sponsored ADR...

Discover more stocks with a high price target

Valneva 268.86%

CureVac N.V. 117.96%

Moderna 81.31%

Bavarian Nordic 59.49%

Teamviewer 56.15%

RWE 47.84%

Nel ASA 47.09%

Alibaba Group Holding Ltd 43.74%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now